Dan Diamond

Can Drug Companies Survive Their Martin Shkreli Moment?

The pharmaceutical industry has been under scrutiny for the past month, after one executive’s decision to hike the price of a drug by more than 5,000% overnight attracted the attention of presidential candidates.

Why California’s ACOs Could Become a Model for the Nation

Organizations experimenting with the much-hyped accountable care organization model are starting to report uneven results. Could California’s pilot programs turn into a national model — even as Medicare’s flagship ACO program shows signs of weakness?

Blue Shield Lost Its Tax Exemption Last Year. Who’s Next?

After 75 years, Blue Shield of California is tax-exempt no more. With a slew of bills and audits underway across the nation, experts say to expect further scrutiny of not-for-profit insurers and hospitals — and possibly, a wave of other health care organizations losing tax-exempt status, too.